{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:51:31Z","timestamp":1762113091307},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.exppara.2007.12.001","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T12:17:44Z","timestamp":1201609064000},"page":"637-640","source":"Crossref","is-referenced-by-count":28,"title":["In vitro trypanocidal activity of the anti-helminthic drug niclosamide"],"prefix":"10.1016","volume":"118","author":[{"given":"Karin","family":"Merschjohann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Steverding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2007.12.001_bib1","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2007.12.001_bib2","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitology Research"},{"key":"10.1016\/j.exppara.2007.12.001_bib3","first-page":"329","article-title":"Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats","volume":"14","author":"Chang","year":"2006","journal-title":"Journal of Food and Drug Analysis"},{"key":"10.1016\/j.exppara.2007.12.001_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"issue":"Suppl.","key":"10.1016\/j.exppara.2007.12.001_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S0031182097001182","article-title":"The current status of antiparasitic chemotherapy","volume":"114","author":"Croft","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2007.12.001_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davis","year":"1993","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.exppara.2007.12.001_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.actatropica.2005.01.005","article-title":"Anti-trypanosomal activities of DNA topoisomerase inhibitors","volume":"93","author":"Deterding","year":"2005","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2007.12.001_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends in Parasitology"},{"key":"10.1016\/j.exppara.2007.12.001_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1471-4922(00)01827-4","article-title":"African bovine trypanosomiasis: the problem of drug resistance","volume":"17","author":"Geerts","year":"2001","journal-title":"Trends in Parasitology"},{"key":"10.1016\/j.exppara.2007.12.001_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0031182000000822","article-title":"In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei","volume":"80","author":"Hirumi","year":"1980","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2007.12.001_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2007.12.001_bib12","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.41.9.1922","article-title":"Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to d,l-\u03b1-difluoromethylornithine","volume":"41","author":"Iten","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.exppara.2007.12.001_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0308-521X(98)00086-9","article-title":"Measuring the costs of African animal trypanosomiasis, the potential benefits of control and returns to research","volume":"59","author":"Kristjanson","year":"1999","journal-title":"Agricultural Systems"},{"key":"10.1016\/j.exppara.2007.12.001_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2001-17351","article-title":"In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense","volume":"67","author":"Merschjohann","year":"2001","journal-title":"Planta Medica"},{"key":"10.1016\/j.exppara.2007.12.001_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-5-3","article-title":"In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators","volume":"5","author":"Merschjohann","year":"2006","journal-title":"Kinetoplastid Biology and Disease"},{"key":"10.1016\/j.exppara.2007.12.001_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1286-4579(01)01432-0","article-title":"Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle","volume":"3","author":"Matovu","year":"2001","journal-title":"Microbes and Infection"},{"key":"10.1016\/j.exppara.2007.12.001_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.exppara.2007.12.001_bib18","first-page":"45","article-title":"A novel in vitro screening assay for trypanocidal activity using the fluorescent dye BCECF-AM","volume":"46","author":"Obexer","year":"1995","journal-title":"Tropical Medicine and Parasitology"},{"key":"10.1016\/j.exppara.2007.12.001_bib19","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"Priotto","year":"2006","journal-title":"PLoS Clinical Trials"},{"key":"10.1016\/j.exppara.2007.12.001_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue\u00ae assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro","volume":"68","author":"R\u00e4z","year":"1997","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2007.12.001_bib21","series-title":"Trypanosomiasis and Leishmaniasis: Biology and Control","first-page":"259","article-title":"Drug resistance in trypanosomatids","author":"Ross","year":"1997"},{"key":"10.1016\/j.exppara.2007.12.001_bib22","unstructured":"WHO, 2002. WHO Specifications and Evaluations for Public Health Pesticides: Niclosamide. World Health Organisation, Geneva. Available from: http:\/\/www.who.int\/whopes\/quality\/en\/Niclosamide.pdf."},{"key":"10.1016\/j.exppara.2007.12.001_bib23","unstructured":"WHO, 2006. African trypanosomiasis (sleeping sickness). World Health Organization Fact Sheet 259. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/."},{"key":"10.1016\/j.exppara.2007.12.001_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm0902-908b","article-title":"Resurrecting the resurrection drug","volume":"8","author":"Wickware","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.exppara.2007.12.001_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0001-706X(91)90050-T","article-title":"Evaluation of d, l-\u03b1-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei","volume":"48","author":"Zweygarth","year":"1991","journal-title":"Acta Tropica"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489407003104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489407003104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T08:09:24Z","timestamp":1588320564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489407003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0014489407003104"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2007.12.001","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}